We found the expression of PCNAP1 to be at relatively high and stable levels in cancer tissue and the plasma of HCC patients, and that PCNAP1 levels correlated with alpha-fetoprotein (AFP), a clinical tumor marker of HCC. Here, AFP is linked to hepatocellular carcinoma.